These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 12811672)

  • 1. Tetanus immunisation in geriatric patients with accidental wounds: how much is needed?
    Hüllstrung HD; Mäusezahl D; Feuz M; Herzog C; Conzelmann M; Zimmerli W
    Swiss Med Wkly; 2003 Apr; 133(15-16):227-32. PubMed ID: 12811672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tetanus immunity and physician compliance with tetanus prophylaxis practices among emergency department patients presenting with wounds.
    Talan DA; Abrahamian FM; Moran GJ; Mower WR; Alagappan K; Tiffany BR; Pollack CV; Steele MT; Dunbar LM; Bajani MD; Weyant RS; Ostroff SM
    Ann Emerg Med; 2004 Mar; 43(3):305-14. PubMed ID: 14985655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seroprevalence of tetanus toxoid antibody and booster vaccination efficacy in Japanese travelers.
    Mizuno Y; Yamamoto A; Komiya T; Takeshita N; Takahashi M
    J Infect Chemother; 2014 Jan; 20(1):35-7. PubMed ID: 24462422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decline of tetanus antitoxin level with age in taiwan.
    Wu CJ; Ko HC; Lee HC; Tsai WC; Li MG; Pao YZ; Lee NY; Chang CM; Shih HI; Ko WC
    J Formos Med Assoc; 2009 May; 108(5):395-401. PubMed ID: 19443293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tetanus immunity in individuals aged 50 years or older in Kashan, Iran.
    Razzaghi R; Khalifesoltani A; Heravi MM; Akbari H
    Acta Med Iran; 2011; 49(6):379-82. PubMed ID: 21874642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Booster effect of low doses of tetanus toxoid in elderly vaccinees.
    Björkholm B; Hagberg L; Sundbeck G; Granström M
    Eur J Clin Microbiol Infect Dis; 2000 Mar; 19(3):195-9. PubMed ID: 10795592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age- and sex-determined differences in the establishment of tetanus antitoxin production in guinea-pigs.
    Réthy LA; Géresi M; Réthy L
    Acta Vet Hung; 2001; 49(1):25-30. PubMed ID: 11402687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune status and booster effects of low doses of tetanus toxoid in Swedish medical personnel.
    Björkholm B; Wahl M; Granström M; Hagberg L
    Scand J Infect Dis; 1994; 26(4):471-5. PubMed ID: 7984981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunity and immunization of children against tetanus in sweden.
    Christenson B; Böttiger M
    Scand J Infect Dis; 1991; 23(5):643-7. PubMed ID: 1767261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunity to diphtheria and tetanus in England and Wales.
    Maple PA; Jones CS; Wall EC; Vyseb A; Edmunds WJ; Andrews NJ; Miller E
    Vaccine; 2000 Sep; 19(2-3):167-73. PubMed ID: 10930669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Duration of tetanus immunoglobulin G titres following basic immunisation of horses.
    Kendall A; Anagrius K; Gånheim A; Rosanowski SM; Bergström K
    Equine Vet J; 2016 Nov; 48(6):710-713. PubMed ID: 26284567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antitoxin titres after tetanus immunisation. Results following use of adsorbate and liquid vaccine for the third injection].
    Gross E; Bartels H; Körner L; Kindt H
    Munch Med Wochenschr; 1970 May; 112(18):846-50. PubMed ID: 5467727
    [No Abstract]   [Full Text] [Related]  

  • 13. Neonatal tetanus despite protective serum antitoxin concentration.
    Maselle SY; Matre R; Mbise R; Hofstad T
    FEMS Microbiol Immunol; 1991 Jun; 3(3):171-5. PubMed ID: 1878260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tetanus immunisation in the elderly population.
    Reid PM; Brown D; Coni N; Sama A; Waters M
    J Accid Emerg Med; 1996 May; 13(3):184-5. PubMed ID: 8733655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adequate immune response to tetanus toxoid and failure of vitamin A and E supplementation to enhance antibody response in healthy children.
    Kutukculer N; Akil T; Egemen A; Kurugöl Z; Akşit S; Ozmen D; Turgan N; Bayindir O; Cağlayan S
    Vaccine; 2000 Jul; 18(26):2979-84. PubMed ID: 10825599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seroprevalence of tetanus antibody in Turkish population and effectiveness of single-dose tetanus toxoid.
    Cavuslu S; Oncul O; Altunay H; Ozsoy MF; Kocak N
    Eur J Clin Microbiol Infect Dis; 2003 Jul; 22(7):431-3. PubMed ID: 12884073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tetanus immunity among pregnant women attending antenatal care in Dar es Salaam, Tanzania.
    Aboud S; Lyamuya EF; Kristoffersen EK; Matre R
    Afr J Reprod Health; 2002 Aug; 6(2):87-93. PubMed ID: 12476720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ELISA for the routine determination of antitoxic immunity to tetanus.
    Simonsen O; Bentzon MW; Heron I
    J Biol Stand; 1986 Jul; 14(3):231-9. PubMed ID: 3759998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seroprotection against tetanus in patients attending an emergency department in Belgium and evaluation of a bedside immunotest.
    Stubbe M; Swinnen R; Crusiaux A; Mascart F; Lheureux PE
    Eur J Emerg Med; 2007 Feb; 14(1):14-24. PubMed ID: 17198321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistence of antibody after accelerated immunisation with diphtheria/tetanus/pertussis vaccine.
    Ramsay ME; Corbel MJ; Redhead K; Ashworth LA; Begg NT
    BMJ; 1991 Jun; 302(6791):1489-91. PubMed ID: 1855015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.